{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:06:19Z","timestamp":1792026379165,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI072195"],"award-info":[{"award-number":["R01 AI072195"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL112671"],"award-info":[{"award-number":["R01 HL112671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI095213"],"award-info":[{"award-number":["T32 AI095213"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI025780"],"award-info":[{"award-number":["R01 AI025780"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI125045"],"award-info":[{"award-number":["R01AI125045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI102618"],"award-info":[{"award-number":["R01 AI102618"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.051","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T16:54:20Z","timestamp":1572886460000},"page":"620-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens"],"prefix":"10.1016","volume":"38","author":[{"given":"Maureen M.","family":"Hester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrono K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambily","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Khoshkenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3799-3064","authenticated-orcid":false,"given":"Stuart M.","family":"Levitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.051_b0005","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.051_b0010","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/CVI.00463-13","article-title":"Characterization and optimization of the glucan particle-based vaccine platform","volume":"20","author":"Huang","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0015","doi-asserted-by":"crossref","first-page":"e00178","DOI":"10.1128\/mBio.00178-11","article-title":"Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans","volume":"2","author":"Agarwal","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4049\/jimmunol.1200603","article-title":"Relative contributions of Dectin-1 and complement to immune responses to particulate \u03b2-glucans","volume":"189","author":"Huang","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0025","doi-asserted-by":"crossref","first-page":"e00164","DOI":"10.1128\/mBio.00164-10","article-title":"Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles","volume":"1","author":"Huang","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0030","doi-asserted-by":"crossref","first-page":"e01905","DOI":"10.1128\/mBio.01905-15","article-title":"Protection against experimental cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extracts","volume":"6","author":"Specht","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0035","doi-asserted-by":"crossref","first-page":"e01872","DOI":"10.1128\/mBio.01872-17","article-title":"Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and cryptococcal species","volume":"8","author":"Specht","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0040","first-page":"1102","article-title":"Recombinant vaccines and the development of new vaccine strategies","volume":"45","author":"Nascimento","year":"2012","journal-title":"Braz J Med Biol Res = Revista brasileira de pesquisas medicas e biologicas"},{"key":"10.1016\/j.vaccine.2019.10.051_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00003495-199652020-00010","article-title":"Acellular pertussis vaccine (Infanrix\u2122-DTPa; SB-3)","volume":"52","author":"Patel","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2019.10.051_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004261","article-title":"Analysis of the genome and transcriptome of Cryptococcus neoformans var. grubii reveals complex RNA expression and microevolution leading to virulence attenuation","volume":"10","author":"Janbon","year":"2014","journal-title":"PLOS Genetics"},{"key":"10.1016\/j.vaccine.2019.10.051_b0055","unstructured":"https:\/\/blast.ncbi.nlm.nih.gov\/Blast.cgi?PAGE=Proteins."},{"key":"10.1016\/j.vaccine.2019.10.051_b0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2004.05.028","article-title":"Improved prediction of signal peptides: SignalP 3.0","volume":"340","author":"Dyrl\u00f8v Bendtsen","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0065","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/IAI.70.10.5485-5493.2002","article-title":"Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-cell responses","volume":"70","author":"Huang","year":"2002","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2019.10.051_b0070","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1073\/pnas.181331398","article-title":"Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans","volume":"98","author":"Levitz","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.10.051_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/jof4010039","article-title":"FungiDB: An integrated bioinformatic resource for fungi and oomycetes","volume":"4","author":"Basenko","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.vaccine.2019.10.051_b0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/1574-6976.12020","article-title":"The secretory pathway: exploring yeast diversity","volume":"37","author":"Delic","year":"2013","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.10.051_b0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/EC.00370-07","article-title":"Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence","volume":"7","author":"Rodrigues","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2019.10.051_b0090","doi-asserted-by":"crossref","first-page":"e01087","DOI":"10.1128\/mBio.01087-13","article-title":"The Cryptococcus neoformans transcriptome at the site of human meningitis","volume":"5","author":"Chen","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0095","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.4049\/jimmunol.168.6.2872","article-title":"Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors","volume":"168","author":"Mansour","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0100","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/520536","article-title":"Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein","volume":"196","author":"Specht","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.051_b0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2018.04.004","article-title":"The glycoscience of immunity","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nchembio.1403","article-title":"Adaptive immune activation: glycosylation does matter","volume":"9","author":"Wolfert","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0115","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01143-07","article-title":"Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model","volume":"76","author":"Chen","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.10.051_b0120","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.160.5.2393","article-title":"IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible Mice (C57BL\/6)","volume":"160","author":"Huffnagle","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02087-18","article-title":"Cryptococcus neoformans Cda1 and its chitin deacetylase activity are required for fungal pathogenesis","volume":"9","author":"Upadhya","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.051_b0130","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41598-018-21039-z","article-title":"Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection","volume":"8","author":"Firacative","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.10.051_b0135","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/pmic.200800713","article-title":"A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins","volume":"9","author":"Young","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2019.10.051_b0140","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1002\/pmic.201300213","article-title":"Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses","volume":"13","author":"Chaturvedi","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2019.10.051_b0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/microorganisms5030049","article-title":"Transcriptional analysis allows genome reannotation and reveals that Cryptococcus gattii VGII undergoes nutrient restriction during infection","volume":"5","author":"Ferrareze","year":"2017","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2019.10.051_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1567-1364.2006.00198.x","article-title":"Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans","volume":"7","author":"Eigenheer","year":"2007","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.vaccine.2019.10.051_b0155","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1128\/mSphere.00023-18","article-title":"A predicted mannoprotein participates in Cryptococcus gattii capsular structure","volume":"3","author":"Reuwsaat","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2019.10.051_b0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12866-015-0532-3","article-title":"Secretome profiling of Cryptococcus neoformans reveals regulation of a subset of virulence-associated proteins and potential biomarkers by protein kinase A","volume":"15","author":"Geddes","year":"2015","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2019.10.051_b0165","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/EC.00052-15","article-title":"Cryptococcus strains with different pathogenic potentials have diverse protein secretomes","volume":"14","author":"Campbell","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2019.10.051_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006051","article-title":"Integrated activity and genetic profiling of secreted peptidases in Cryptococcus neoformans reveals an aspartyl peptidase required for low pH survival and virulence","volume":"12","author":"Clarke","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.10.051_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004037","article-title":"A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule","volume":"10","author":"Park","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.10.051_b0180","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/IAI.68.11.6196-6201.2000","article-title":"The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice","volume":"68","author":"Mandel","year":"2000","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:15:21Z","timestamp":1777536921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314318"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}